OnDosis key facts
- Developer of a personalized medicine device intended to improve how patients manage and take medications.
- It has raised $32.4M; the latest was Later Stage VC ($5.6M) in Jul 2025.
- Notable investors include Boston Consulting Group, DIG Investment, Sanner Ventures, Aeternum Capital, Albonja — 9 tracked in total.
- Status: Privately Held (backing).
- ·Watch OnDosis: the Monday email on marks, rounds and moves
OnDosis funding rounds
No funding rounds for OnDosis are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
OnDosis investors
9 investors are on record for OnDosis, including Boston Consulting Group, DIG Investment, Sanner Ventures and Aeternum Capital.
About OnDosis
Developer of a personalized medicine device intended to improve how patients manage and take medications. The company offers a dosage manager supporting flexible delivery of pellets, granules, mini tablets, and powders with integrated digital technologies and IoT connectivity, enabling patients and healthcare providers to achieve precise dosing and enhanced treatment management.
- Sector
- Healthcare
- HQ
- Molndal, Sweden
- Founded
- 2017
- Employees
- 22
- Website
- ondosis.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
OnDosis doesn't have a valuation on record yet — one is published once a priced round, a reported valuation, fund marks, or secondary prints surface in our sources. The rest of the record below builds toward it.